Increased use of organoids in cancer research: The Würzburg lighthouse project "Preclinical Models" is working towards this ...

Initial AX-0810 data show no safety signals after 4 weeks of dosing and pharmacokinetics consistent with non-clinical data; ...

Program will expand access in certain regions where Revuforj is not available commercially, as permitted by local regulations -- Program will ...

As BioMendics prepares to share its progress during the 2026 J.P. Morgan Healthcare Conference and Biotech Showcase, the Ohio-based biotech is advancing what could become the first disease-modifying ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared ...

ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...

So many characters were brought to the big screen in Marvel's X-Men movies. These seven castings were the best of them all.

The emergence of next-generation KRAS G12C inhibitors has led Verastem Oncology to change course. | The emergence of ...

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

Scientists and clinicians reported advances that addressed conditions once thought irreversible, from congenital deafness and ...

A San Diego startup may have created what the scientific community has talked about for decades – a kind of universal flu ...